The current standard for breast PET imaging is 18F-FDG. The heterogeneity of 18F-FDG
uptake in breast cancer limits its utility, varying greatly among receptor status …

Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer
worldwide, with an estimated 2.3 million new cases (11.7%), followed by lung cancer …

Breast cancer (BC) is the most common cancer among females with more than 2 million new
cases diagnosed worldwide in 2018. Although the prognosis in the majority of cases in the …

Positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG-PET) has become
a standard imaging procedure in the management of malignant diseases including breast …

Background Nuclear medicine is on the constant search of precision radiopharmaceutical
approaches to improve patient management. Although discordant expression of the …

A noninvasive technology that quantitatively measures the activity of oncogenic signaling
pathways could have a broad impact on cancer diagnosis and treatment with targeted …

We hypothesized that functional imaging with 64Cu-DOTA-trastuzumab PET/CT would
predict the response to the antibody–drug conjugate trastuzumab–emtansine (T-DM1) …

Positron emission tomography (PET) scanning has gained widespread acceptance for the
diagnosis, staging, and management of a variety of malignancies, including breast cancer …

The purpose of this study was to determine the safety, distribution, internal dosimetry, and
initial human epidermal growth factor receptor 2 (HER2)–positive tumor images of 64Cu …

Breast cancers (BCs) with high human epidermal growth factor receptor type 2 (HER2)
expression are most likely to respond to trastuzumab; however, the mechanisms of action of …